Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Robert P. Edwards
University of Pittsburgh - Magee-Women's Research Institute
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
62
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Novel Murine Cell Lines with Defined Mutations Model Different Histological Subtypes of Ovarian Cancer
Number of pages: 58
Posted: 24 May 2023
Lixin Zhang
,
Yusi Fang
,
Ibrahim Uygun
,
Mary Strange
,
Syed Zaidi
,
Julia Knight
,
Mackenzy Radolec
,
Esther Elishaev
,
George Tseng
,
Sandra Cascio
, Robert P. Edwards,
Ronald Buckanovich
and
Anda Vlad
University of Pittsburgh - Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh - Department of Biostatistics, University of Pittsburgh - Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh - Magee-Women's Research Institute, University of Pittsburgh - Magee-Women's Research Institute, University of Pittsburgh - Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh - Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh - Department of Pathology, University of Pittsburgh - Department of Biostatistics, University of Pittsburgh - Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh - Magee-Women's Research Institute, University of Pittsburgh - Department of Obstetrics, Gynecology and Reproductive Sciences and University of Pittsburgh - Department of Obstetrics, Gynecology and Reproductive Sciences
Downloads
41
(1,170,409)
View PDF
Download
Abstract:
preclinical model, high grade serous, endometrioid, ovarian cancer, Trp53, Kras, Pten, MUC1
2.
Targeting Cd47-Sirpa Axis Shows Potent Preclinical Anti-Tumor Activity as Monotherapy and Synergizes With Parp Inhibition
Number of pages: 35
Posted: 17 Oct 2022
Hussein Al-Sudani
,
Ying Ni
,
Philip Jones
,
Huseyin Karakilic
,
Lei Cui
,
Lisa D.S. Johnson
,
Peter G. Rose
,
Alexander Olawaiye
, Robert P. Edwards,
Robert A. Uger
,
Gloria Lin
and
Haider Mahdi
Einstein Medical Center Montgomery - Internal Medicine Department, Cleveland Clinic - Center for Immunotherapy & Precision Immuno-Oncology, University of Pittsburgh - Magee-Women's Research Institute, University of Pittsburgh - Magee-Women's Research Institute, Trillium Therapeutics Inc,, Trillium Therapeutics Inc,, Cleveland Clinic - Division of Gynecologic Cancer, University of Pittsburgh - Magee-Women's Research Institute, University of Pittsburgh - Magee-Women's Research Institute, Trillium Therapeutics Inc,, Trillium Therapeutics Inc, and University of Pittsburgh - Magee-Women's Research Institute
Downloads
21
(1,436,435)
View PDF
Download
Abstract:
Feedback